| Dr Emilia C Dulgheru, MD | |
|
1506 S Lone Star Way Ste 3, Edinburg, TX 78539-4977 | |
| (956) 362-2400 | |
| (956) 362-2404 |
| Full Name | Dr Emilia C Dulgheru |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 29 Years |
| Location | 1506 S Lone Star Way Ste 3, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407850100 | NPI | - | NPPES |
| 165809805 | Medicaid | TX | |
| 215107 | Other | MO | BLUE CROSS BLUE SHIELD |
| 207215203 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | L7361 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Medical Foundation | 1153409867 | 86 |
News Archive
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.
A new survey from Sleep Cycle, the best-selling alarm clock application, reveals that Americans turn to a number of foods, drinks, herbs and bedtime rituals to get a good night's sleep.
Bederra Corporation, a Houston, TX-based diversified medical services provider, announced the company is in discussions to acquire Basic Solutions, Inc., a Houston, TX-based company specializing in mobile diagnostic services.
› Verified 4 days ago
| Entity Name | Renaissance Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.
A new survey from Sleep Cycle, the best-selling alarm clock application, reveals that Americans turn to a number of foods, drinks, herbs and bedtime rituals to get a good night's sleep.
Bederra Corporation, a Houston, TX-based diversified medical services provider, announced the company is in discussions to acquire Basic Solutions, Inc., a Houston, TX-based company specializing in mobile diagnostic services.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emilia C Dulgheru, MD Po Box 749, Pharr, TX 78577-1614 Ph: (956) 362-2400 | Dr Emilia C Dulgheru, MD 1506 S Lone Star Way Ste 3, Edinburg, TX 78539-4977 Ph: (956) 362-2400 |
News Archive
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.
A new survey from Sleep Cycle, the best-selling alarm clock application, reveals that Americans turn to a number of foods, drinks, herbs and bedtime rituals to get a good night's sleep.
Bederra Corporation, a Houston, TX-based diversified medical services provider, announced the company is in discussions to acquire Basic Solutions, Inc., a Houston, TX-based company specializing in mobile diagnostic services.
› Verified 4 days ago
Daniela Hernandez, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3575 Fax: 956-362-3584 | |
Dr. Carlos Javier Cardenas, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5520 Leonardo Da Vinci, Ste 100, Edinburg, TX 78539 Phone: 956-362-3636 Fax: 956-362-2699 | |
Chi Lun Pui, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michael Angelo, Ste. 400, Edinburg, TX 78539 Phone: 956-362-3553 | |
Dr. Brandon Robert Cantazaro, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3575 Fax: 956-362-3584 | |
Dr. Roque Masaharu Mifuji Lira, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3553 Fax: 956-362-3584 | |
Asma Salih Mohammed Tarjmani, Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-369-5100 | |
James Walter Castillo Ii, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677 Fax: 956-362-7253 |